Tags:
Rvol: 3.21
Float: 56.57mm
Market Cap:35.58m
Short Float 1.33%
Catalyst: Vyne Therapeutics Announces First Vitiligo Patient Dosed In Phase 1A/B Clinical Trial Of Novel Bet Inhibitor Vyn201
The set-up: Breakout trade on breaking news
What I did Right: sized in right
What I did Wrong:too wide a stop
Where I could improve: tighter stop
Trade grade: B
-------------------------------------
Big-picture:
Trade parameters:L 0.3583 x SL 0.302 X 0.480 2R PT
Entry:
Trade Management: closed out trade on 1min EMA after volume died.
Exit
Execution detail:
Date/time | Symbol | Qty | Price | Position |
---|---|---|---|---|
2023-01-09 16:08:28 | VYNE | 445 | $0.3583 | 445 |
2023-01-09 16:20:39 | VYNE | -445 | $0.3702 | 0 |
You need to log into your Tradervue account to leave a comment. If you don't have one,
it takes
just a few seconds to sign up, and it's free!